ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.473,29
-1,13%
S&P 500
5.266,95
-0,74%
Dow Jones
38.441,54
-1,06%
Euro vs US Dollar
1,08021
-0,47%
Bitcoin
67.588,75
-1,03%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Vereinigtes Königreich
  5. LSE
  6. Silver Falcon (SILF)

  7. Silver Falcon (SILF) News

SILF

Silver Falcon (SILF)

Silver Falcon
Von:
Sortieren nach:
 Showing the most relevant articles for your search:LSE:SILF
DatumZeitQuelleÜberschriftSymbolFirma
08/09/202318h11RNS Non-RegulatoryHemogenyx Pharmaceuticals PLC CBR Patent Application UpdateLSE:SILFSilver Falcon
23/03/202314h32RNS Non-RegulatoryHemogenyx Pharmaceuticals PLC HEMO-CAR-T Analytical Release Tests CompletedLSE:SILFSilver Falcon
23/01/202308h00RNS Non-RegulatoryHemogenyx Pharmaceuticals PLC HEMO-CAR-T 3rd Process Qualification Run CompletedLSE:SILFSilver Falcon
09/01/202308h00RNS Non-RegulatoryHemogenyx Pharmaceuticals PLC Single CBR Can Treat Multiple VirusesLSE:SILFSilver Falcon
04/01/202308h00RNS Non-RegulatoryHemogenyx Pharmaceuticals PLC HEMO-CAR-T Process Qualification Run CompletedLSE:SILFSilver Falcon
12/12/202208h00RNS Non-RegulatoryHemogenyx Pharmaceuticals PLC HEMO-CAR-T First PQ Run CompletedLSE:SILFSilver Falcon
18/11/202216h19RNS Non-RegulatoryHemogenyx Pharmaceuticals PLC HEMO-CAR-T Process Development Runs CompletedLSE:SILFSilver Falcon
01/09/202209h45RNS Non-RegulatoryHemogenyx Pharmaceuticals PLC Presentation at H.C. Wainwright Global ConferenceLSE:SILFSilver Falcon
08/07/202213h25RNS Non-RegulatoryHemogenyx Pharmaceuticals PLC Investor Webinar RecordingLSE:SILFSilver Falcon
27/06/202208h00RNS Non-RegulatoryHemogenyx Pharmaceuticals PLC Investor WebinarLSE:SILFSilver Falcon
16/05/202208h02RNS Non-RegulatoryHemogenyx Pharmaceuticals PLC Immuno-Oncology Summit Europe PresentationLSE:SILFSilver Falcon
16/02/202208h00RNS Non-RegulatoryHemogenyx Pharmaceuticals PLC HEMO-CAR-T pre-IND Meeting RequestLSE:SILFSilver Falcon
05/01/202208h00RNS Non-RegulatoryHemogenyx Pharmaceuticals PLC H.C. Wainwright Bioconnect ConferenceLSE:SILFSilver Falcon
18/10/202108h00RNS Non-RegulatoryHemogenyx Pharmaceuticals PLC Lease of New York Mink Building Custom LaboratoryLSE:SILFSilver Falcon
02/07/202112h23RNS Non-RegulatoryHemogenyx Pharmaceuticals PLC Corporate PresentationLSE:SILFSilver Falcon
08/03/202108h00RNS Non-RegulatoryHemogenyx Pharmaceuticals PLC H.C. Wainwright Investment ConferenceLSE:SILFSilver Falcon
19/10/202008h00RNS Non-RegulatoryHemogenyx Pharmaceuticals PLC Presentation at the American Society of HematologyLSE:SILFSilver Falcon
14/08/202008h00RNS Non-RegulatoryHemogenyx Pharmaceuticals PLC Presentations at Cancer Immunotherapy SymposiaLSE:SILFSilver Falcon
31/07/202008h00RNS Non-RegulatoryHemogenyx Pharmaceuticals PLC Broker's Research NoteLSE:SILFSilver Falcon
10/07/202014h00RNS Non-RegulatoryHemogenyx Pharmaceuticals PLC US Subsidiary Change of NameLSE:SILFSilver Falcon
06/07/202008h00RNS Non-RegulatoryHemogenyx Pharmaceuticals PLC New Corporate Video and Investor WebinarLSE:SILFSilver Falcon
06/11/201908h00RNS Non-RegulatoryHemogenyx Pharmaceuticals PLC Presentation at the NY Oncology Investor Conf.LSE:SILFSilver Falcon
21/10/201908h00RNS Non-RegulatoryHemogenyx Pharmaceuticals PLC Presentation at NY Stem Cell Foundation conferenceLSE:SILFSilver Falcon
12/09/201908h01RNS Non-RegulatoryHemogenyx Pharmaceuticals PLC Hemogenyx scientific advisor receives Lasker AwardLSE:SILFSilver Falcon
08/06/201808h00RNS Non-RegulatoryHemogenyx Pharmaceuticals PLC Investor presentationLSE:SILFSilver Falcon
14/05/201808h00RNS Non-RegulatoryHemogenyx Pharmaceuticals PLC Development AgreementLSE:SILFSilver Falcon
08/05/201808h01RNS Non-RegulatoryHemogenyx Pharmaceuticals PLC Research Collaboration with Rockefeller UniversityLSE:SILFSilver Falcon
01/03/201808h02RNS Non-RegulatoryHemogenyx Pharmaceuticals PLC Align Research Initiation of CoverageLSE:SILFSilver Falcon
11/01/201808h00RNS Non-RegulatoryHemogenyx Pharmaceuticals PLC Hemogenyx Welcomes N.Y. Lt. Governor to its LabsLSE:SILFSilver Falcon
04/10/201712h16UK RegulatorySilver Falcon PLC Result of General MeetingLSE:SILFSilver Falcon
 Showing the most relevant articles for your search:LSE:SILF

Kürzlich von Ihnen besucht

NASDAQ
MGIH
Millennium
USOTC
USIC
Uncles Ice Cream (PK)
BIT
F18256
Vontobel Financial Produ...
BIT
UC896K
Unicredit Bank
TSXV
MAS.RT
Mas Gold
DBI
2DWU
DAX Risk Control 15% RV ...
ASX
SRY
Story I
BIT
UC92RN
Unicredit Bank
BIT
UB82HB
Unicredit Bank
EU
FR0000578601
Rep Fse Oat/strip10 2032
AMEX
TWH
Washtenaw
NASDAQ
HDRAW
BIT
UC7PX2
Unicredit Bank
NASDAQ
GDRX
GoodRx
LSE
0J50
Hess
EU
I385T
I385T
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten